Arcellx to participate at the 2025 morgan stanley global healthcare conference

Redwood city, calif.--(business wire)--arcellx, inc. (nasdaq: aclx), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the 2025 morgan stanley global healthcare conference on wednesday, september 10, 2025 at 1:05 p.m. et. a live webcast of this discussion will be accessible from arcellx's website at www.arcellx.com in.
ACLX Ratings Summary
ACLX Quant Ranking